Skip to content

Clinical trials

Phase 2 Spinal Cord Injuries trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Spinal Cord Injuries Phase: Phase 2 Clear all

115 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20033
20041
20062
20077
20084
20092
20107
20112
20127
20136
20142
20154
20167
20175
20185
201913
20208
20215
20223
20234
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Unknown status17
Terminated13
Active, not recruiting6
Recruiting6
Withdrawn5
Not yet recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
US Department of Veterans Affairs10
VA Office of Research and Development5
Brigham and Women's Hospital4
James J. Peters Veterans Affairs Medical Center4
Kessler Foundation4
Medstar Health Research Institute4
Northwestern University4
Spaulding Rehabilitation Hospital3
Third Affiliated Hospital, Sun Yat-Sen University3
University of British Columbia3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Spinal Cord Injuries115
Osteoporosis8
Spinal Cord Diseases7
Urinary Bladder, Neurogenic7
Wounds and Injuries7
Bone Diseases, Metabolic6
Neuralgia6
Quadriplegia6
Central Nervous System Diseases5
Nervous System Diseases5

Trials

Showing 76 to 100 of 115. Each trial links to its page on Pharma Observatory.

15 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.